AI assistant
Sending…
CIMPRESS plc — Director's Dealing 2022
Jul 18, 2022
31904_dirs_2022-07-18_1b39595c-c3e2-4e46-8c75-58831bec22e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: CIMPRESS plc (CMPR)
CIK: 0001262976
Period of Report: 2022-06-30
Reporting Person: Keane Robert S (Director, CEO, Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-12 | Ordinary Shares | S | 300000 | $83.04 | Disposed | 88128 | Indirect |
| 2021-10-12 | Ordinary Shares | P | 300000 | $83.04 | Acquired | 668200 | Indirect |
| 2021-10-12 | Ordinary Shares | S | 300000 | $83.04 | Disposed | 92088 | Indirect |
| 2021-10-12 | Ordinary Shares | P | 300000 | $83.04 | Acquired | 968200 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 800 | Direct |
| Ordinary Shares | 109181 | Indirect |
| Ordinary Shares | 28375 | Indirect |
| Ordinary Shares | 86861 | Indirect |
| Ordinary Shares | 86861 | Indirect |
| Ordinary Shares | 51900 | Indirect |
| Ordinary Shares | 780000 | Indirect |
| Ordinary Shares | 368200 | Indirect |
Footnotes
F1: These purchases and sales are internal transactions for the Reporting Person's estate planning purposes among trusts and companies that are controlled by the Reporting Person.
F2: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.
F3: Includes 368,200 shares held by Third Delaware 2011, LLC, of which the Third Delaware 2011 GST-Exempt Trust is the sole shareholder.
More from CIMPRESS plc
Regulatory Filings
2026
May 11
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 2
Interim / Quarterly Report
2026
Jan 29
Regulatory Filings
2026
Jan 28